Q1 2018 EPS Estimates for CME Group Lifted by Analyst (CME)

CME Group (NASDAQ:CME) – Investment analysts at Jefferies Group raised their Q1 2018 earnings per share estimates for shares of CME Group in a research note issued on Tuesday, April 10th. Jefferies Group analyst D. Fannon now anticipates that the financial services provider will post earnings of $1.84 per share for the quarter, up from their prior estimate of $1.80.

How to Become a New Pot Stock Millionaire

Several other research analysts have also recently weighed in on the company. Goldman Sachs raised CME Group from a “neutral” rating to a “buy” rating and set a $180.00 target price for the company in a research note on Wednesday, February 7th. Zacks Investment Research raised CME Group from a “hold” rating to a “buy” rating and set a $164.00 target price for the company in a research note on Tuesday, January 2nd. BidaskClub cut CME Group from a “buy” rating to a “hold” rating in a research note on Tuesday, December 19th. Citigroup reaffirmed a “buy” rating and set a $172.00 target price (up previously from $155.00) on shares of CME Group in a research note on Monday, January 29th. Finally, Bank of America raised their target price on CME Group from $175.00 to $185.00 and gave the company a “buy” rating in a research note on Thursday, March 8th. Three investment analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the stock. CME Group presently has an average rating of “Buy” and an average price target of $165.57.

Shares of CME stock opened at $161.26 on Thursday. CME Group has a fifty-two week low of $114.82 and a fifty-two week high of $171.71. The stock has a market cap of $55,683.58, a P/E ratio of 34.37, a PEG ratio of 2.24 and a beta of 0.56. The company has a quick ratio of 1.03, a current ratio of 1.03 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last announced its earnings results on Thursday, February 1st. The financial services provider reported $1.12 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.10 by $0.02. CME Group had a return on equity of 7.68% and a net margin of 111.49%. The business had revenue of $900.00 million during the quarter, compared to analysts’ expectations of $886.85 million. During the same quarter last year, the business posted $1.14 earnings per share. The company’s quarterly revenue was down 1.4% on a year-over-year basis.

The business also recently announced a quarterly dividend, which was paid on Monday, March 26th. Stockholders of record on Friday, March 9th were issued a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a dividend yield of 1.74%. This is an increase from CME Group’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend was Thursday, March 8th. CME Group’s dividend payout ratio is currently 58.70%.

In other news, Director Leo Melamed sold 7,300 shares of the company’s stock in a transaction on Monday, February 5th. The stock was sold at an average price of $155.78, for a total transaction of $1,137,194.00. Following the completion of the sale, the director now directly owns 10,537 shares of the company’s stock, valued at $1,641,453.86. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Derek Sammann sold 2,400 shares of the stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $161.66, for a total value of $387,984.00. Following the completion of the sale, the insider now directly owns 40,153 shares of the company’s stock, valued at $6,491,133.98. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 35,699 shares of company stock valued at $5,532,362. 0.57% of the stock is currently owned by company insiders.

A number of institutional investors have recently made changes to their positions in CME. Caisse DE Depot ET Placement DU Quebec lifted its stake in CME Group by 9.9% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 7,791 shares of the financial services provider’s stock worth $1,062,000 after acquiring an additional 700 shares in the last quarter. Vident Investment Advisory LLC purchased a new stake in CME Group in the 3rd quarter worth about $917,000. Cubist Systematic Strategies LLC lifted its stake in CME Group by 353.4% in the 3rd quarter. Cubist Systematic Strategies LLC now owns 3,165 shares of the financial services provider’s stock worth $429,000 after acquiring an additional 2,467 shares in the last quarter. Valeo Financial Advisors LLC purchased a new stake in CME Group in the 3rd quarter worth about $124,000. Finally, Piedmont Investment Advisors LLC lifted its stake in CME Group by 0.9% in the 3rd quarter. Piedmont Investment Advisors LLC now owns 73,118 shares of the financial services provider’s stock worth $9,921,000 after acquiring an additional 673 shares in the last quarter. 83.12% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: “Q1 2018 EPS Estimates for CME Group Lifted by Analyst (CME)” was first reported by Ticker Report and is the property of of Ticker Report. If you are viewing this report on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The correct version of this report can be accessed at https://www.tickerreport.com/banking-finance/3350609/q1-2018-eps-estimates-for-cme-group-lifted-by-analyst-cme.html.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Coca-Cola Hellenic Bottling  Receives GBX 2,607.90 Average Price Target from Brokerages
Coca-Cola Hellenic Bottling Receives GBX 2,607.90 Average Price Target from Brokerages
Analysts Set Bristol-Myers Squibb  Price Target at $64.30
Analysts Set Bristol-Myers Squibb Price Target at $64.30
Brokerages Set Kier Group  PT at $1,495.80
Brokerages Set Kier Group PT at $1,495.80
Universal Technical Institute  versus The Competition Head to Head Survey
Universal Technical Institute versus The Competition Head to Head Survey
Critical Comparison: Tactile Systems Technology  versus Its Competitors
Critical Comparison: Tactile Systems Technology versus Its Competitors
Triggers Hits 24-Hour Trading Volume of $11.74 Million
Triggers Hits 24-Hour Trading Volume of $11.74 Million


Leave a Reply

© 2006-2018 Ticker Report. Google+.